Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,977 public trials 2,028 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Thalidomide in Treating Patients With Asymptomatic, Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

NCT00052416

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +26 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Fletcher Allen Health Care - University Health Center Campus Burlington, Vermont, United States

View Trial Details

Completed

A Study to Assess AFM13 in Patients With Hodgkin Lymphoma

NCT01221571

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations: The University of Texas MD Anderson Cancer Center Houston, Texas, United States

University Hosptial Cologne Cologne, Köln, Germany

University Hospital Würzburg Würzburg, Germany

View Trial Details

Completed

Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma

NCT00005867

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: Stoke Mandeville Hospital Aylesbury-Buckinghamshire, England, United Kingdom

Horton Hospital Banbury, England, United Kingdom

Basildon University Hospital Basildon, England, United Kingdom

Birmingham Heartlands Hospital Birmingham, England, United Kingdom

View all 46 locations

View Trial Details

Completed

Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer

NCT00004061

Conditions: Blast Crisis, Bone Marrow Diseases, Burkitt Lymphoma, +42 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Bone Marrow Transplantation in Treating Patients With Acute Leukemia in First or Second Remission

NCT00002534

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Combination Chemotherapy in Treating Pediatric Patients With Stage III or IV Non-Hodgkin's Lymphoma

NCT00002691

Conditions: Burkitt Lymphoma, DNA Virus Infections, Dendritic Cell Sarcoma, Interdigitating, +17 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Arsenic Trioxide in Treating Patients With Advanced Hematologic Cancer

NCT00003395

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +70 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Other B-cell Cancers

NCT00003658

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +24 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

STI571 Plus Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphocytic Leukemia

NCT00015860

Conditions: Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +20 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States

Stanford University Medical Center Stanford, California, United States

Oregon Cancer Institute Portland, Oregon, United States

View Trial Details

Completed

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

NCT00004065

Conditions: Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +110 more
Locations: Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States

Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions